Position in APGE
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$0
New position
Shares Held
0
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2026
1 quarter on record
Derivatives in APGE
reported options exposure · as of Jun 30, 2026CallValue
$0
CallShares
0
PutValue
$358,371
PutShares
2,700
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Walleye Trading LLC holds $28,211,005 across 28 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
11,407 | $7,112,720 | |
| 2 | MRNA |
Moderna, Inc.
|
101,066 | $7,077,651 | |
| 3 | BNTX |
BioNTech SE
|
25,690 | $2,390,454 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
6,037 | $1,817,318 | |
| 5 | VKTX |
Viking Therapeutics, Inc.
|
33,938 | $1,323,921 | |
| 6 | TGTX |
Tg Therapeutics, Inc.
|
19,679 | $1,081,164 | |
| 7 | CRSP |
CRISPR Therapeutics AG
|
18,595 | $1,014,171 | |
| 8 | ABVX |
Abivax S.A.
|
6,790 | $904,835 |
All Filings in APGE
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $358,371 | 2,700 | Put | Sole | 2026-08-03 | |
| No filing history on record for this holder in this stock. | ||||||